Biolytix AG is a leading, independent specialized laboratory for molecular biological and microbiological analysis, with ISO/IEC 17025 accreditation. Founded in 1998 in Switzerland, Biolytix offers a wide range of services, committed to fulfilling customers’ expectations in a reliable, trustworthy, and confidential manner. The company prides itself on an experienced, highly-qualified, and motivated team. Although information about the last investment is not available, Biolytix's dedication to providing high-quality molecular and microbiological analyses positions it as a promising venture for potential venture capital investment.
There is no investment information
No recent news or press coverage available for Biolytix AG.